The FDA just pulled popular heartburn drug Zantac due to cancer risk

As if things in the world of healthcare weren’t chaotic enough, last week the FDA pulled the popular heartburn medicine ranitidine, brand name Zantac, from the shelves due to a possible cancer link.

Read at Popular Science